Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients
NCT03264690 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2020-03-10
Summary
This study will be conducted to observe the difference in microbiome composition between healthy participants and inflammatory bowel disease (IBD) participants with no anti-tumor necrosis factor (anti-TNF) treatment.
Conditions
Sponsors & Collaborators
-
Eisai Korea Inc.
lead INDUSTRY
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-09-21
- Primary Completion
- 2020-01-16
- Completion
- 2020-01-16
Countries
- South Korea
Study Locations
More Related Trials
-
Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel Diseases
NCT02878395 ·Status: UNKNOWN
-
Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk
NCT02193464 ·Status: RECRUITING
-
CMTS0929 for Inflammatory Bowel Disease
NCT06844708 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
The Comparison Between the Biomarkers in Inflammatory Bowel Disease Patients and General Control Group
NCT03778918 ·Status: UNKNOWN
-
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
NCT05598489 ·Status: UNKNOWN
-
Gut Microbiota in the Healthy Population, Inflammatory Bowel Disease Patients, and Their Relatives
NCT01140802 ·Status: TERMINATED
-
Does the Microbiome in IBD Change Alongside Special Treatment Scenarios?
NCT02526251 ·Status: COMPLETED
-
Predicting IBD Treatment Outcomes With Gut Microbiome Analysis
NCT06453720 ·Status: RECRUITING
-
An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease
NCT00269841 ·Status: COMPLETED ·Phase: PHASE3
-
SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease
NCT07011979 ·Status: RECRUITING
-
Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
NCT07166588 ·Status: ENROLLING_BY_INVITATION
-
Evolution of Lymphocyte Populations Under Biotherapy in Inflammatory Bowel Disease
NCT02693340 ·Status: UNKNOWN
-
A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease
NCT02904590 ·Status: COMPLETED
-
Genome Analysis Across Populations in Inflammatory Bowel Disease
NCT06042387 ·Status: RECRUITING
-
Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis
NCT03765450 ·Status: ACTIVE_NOT_RECRUITING
-
The Effect of Intestinal Microbiota Transplantation for Inflammatory Bowel Diseases
NCT03426683 ·Status: COMPLETED ·Phase: NA
-
Advanced Therapy Registry of IBD Patients
NCT04998084 ·Status: UNKNOWN
-
Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets
NCT03090139 ·Status: COMPLETED
-
A Multicenter Clinical Trial: Efficacy, Safety of Fecal Microbiota Transplantation for Inflammatory Bowel Disease
NCT04521205 ·Status: RECRUITING ·Phase: PHASE1
-
Early Inflammatory Bowel Disease Progression
NCT06756100 ·Status: RECRUITING
-
Characterization of Phenotype and Genotype of Early Onset Enteropathies
NCT02614911 ·Status: RECRUITING
-
Microbiome and Genetic Analysis of Familial IBD
NCT03515070 ·Status: COMPLETED
-
Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success
NCT05702879 ·Status: RECRUITING
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)
NCT01346826 ·Status: COMPLETED ·Phase: PHASE4